Mirae Asset Global ETFs Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
60,255
-1,523
-2% -$55.4K ﹤0.01% 1051
2025
Q1
$2.24M Sell
61,778
-3,956
-6% -$144K ﹤0.01% 1068
2024
Q4
$2.77M Sell
65,734
-6,379
-9% -$268K 0.01% 964
2024
Q3
$4.01M Sell
72,113
-20,711
-22% -$1.15M 0.01% 837
2024
Q2
$3.82M Buy
+92,824
New +$3.82M 0.01% 833